BlueSpruce Investments LP Buys Shares of 6,427 Agilent Technologies, Inc. $A

BlueSpruce Investments LP purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 6,427 shares of the medical research company’s stock, valued at approximately $758,000. Agilent Technologies makes up about 0.0% of BlueSpruce Investments LP’s investment portfolio, making the stock its 22nd biggest holding.

A number of other large investors have also made changes to their positions in A. Ransom Advisory Ltd acquired a new position in Agilent Technologies in the first quarter valued at about $32,000. Central Pacific Bank Trust Division acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at approximately $33,000. Ameritas Advisory Services LLC bought a new stake in Agilent Technologies during the 2nd quarter worth approximately $64,000. Geneos Wealth Management Inc. raised its holdings in Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after buying an additional 212 shares during the period. Finally, True Wealth Design LLC lifted its stake in Agilent Technologies by 3,405.3% in the second quarter. True Wealth Design LLC now owns 666 shares of the medical research company’s stock valued at $79,000 after buying an additional 647 shares in the last quarter. Institutional investors own 87.41% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on A. Citigroup boosted their price objective on shares of Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a report on Tuesday. UBS Group lifted their target price on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. Robert W. Baird raised their price target on shares of Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 25th. Finally, Evercore ISI boosted their price objective on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 7th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $161.77.

Insider Transactions at Agilent Technologies

In other news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Padraig Mcdonnell sold 911 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total value of $130,491.64. Following the completion of the sale, the chief executive officer owned 32,058 shares of the company’s stock, valued at $4,591,987.92. This trade represents a 2.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 16,401 shares of company stock valued at $2,468,962. 0.26% of the stock is currently owned by corporate insiders.

Agilent Technologies Stock Down 2.3%

Shares of A stock opened at $139.56 on Friday. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The stock has a market cap of $39.57 billion, a price-to-earnings ratio of 30.54, a PEG ratio of 4.15 and a beta of 1.27. The firm’s 50-day moving average is $145.59 and its 200-day moving average is $129.02. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The firm had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same quarter in the previous year, the business earned $1.46 earnings per share. The business’s revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be issued a $0.255 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio is presently 22.32%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.